Biomerica reports real-world data showing IBS therapy effectiveness
Go back to Biomerica reports real-world data showing IBS therapy effectiveness| Biomerica, Inc. (NASDAQ: BMRA) | Delayed: 1.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.59 | 52 Week High | $3.25 | |||
| Open | $1.59 | 52 Week Low | $0.80 | |||
| Day High | $1.59 | P/E | N/A | |||
| Day Low | $1.59 | EPS | $-0.06 | |||
| Volume | 1,842 | |||||
| Henry Schein, Inc. (NASDAQ: HSIC) | Delayed: 85.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $85.47 | 52 Week High | $183.00 | |||
| Open | $85.47 | 52 Week Low | $142.64 | |||
| Day High | $85.47 | P/E | 17.34 | |||
| Day Low | $85.47 | EPS | $4.93 | |||
| Volume | 2 | |||||

